- Home
- OPFI vs LUNG Comparison
OPFI vs LUNG Comparison
Compare OPFI & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPFI
- LUNG
- Stock Information
- Founded
- OPFI 2009
- LUNG 1995
- Country
- OPFI United States
- LUNG United States
- Employees
- OPFI N/A
- LUNG N/A
- Industry
- OPFI Finance: Consumer Services
- LUNG Industrial Specialties
- Sector
- OPFI Finance
- LUNG Health Care
- Exchange
- OPFI Nasdaq
- LUNG Nasdaq
- Market Cap
- OPFI N/A
- LUNG 299.3M
- IPO Year
- OPFI N/A
- LUNG 2020
- Fundamental
- Price
- OPFI $9.76
- LUNG $7.77
- Analyst Decision
- OPFI Buy
- LUNG Strong Buy
- Analyst Count
- OPFI 2
- LUNG 7
- Target Price
- OPFI $7.50
- LUNG $12.64
- AVG Volume (30 Days)
- OPFI 1.7M
- LUNG 464.2K
- Earning Date
- OPFI 03-05-2025
- LUNG 04-30-2025
- Dividend Yield
- OPFI 1.24%
- LUNG N/A
- EPS Growth
- OPFI N/A
- LUNG N/A
- EPS
- OPFI 0.36
- LUNG N/A
- Revenue
- OPFI $276,770,000.00
- LUNG $83,789,000.00
- Revenue This Year
- OPFI N/A
- LUNG $17.96
- Revenue Next Year
- OPFI $15.34
- LUNG $18.35
- P/E Ratio
- OPFI $26.86
- LUNG N/A
- Revenue Growth
- OPFI 22.23
- LUNG 22.01
- 52 Week Low
- OPFI $2.35
- LUNG $5.46
- 52 Week High
- OPFI $17.73
- LUNG $10.01
- Technical
- Relative Strength Index (RSI)
- OPFI 44.67
- LUNG 52.56
- Support Level
- OPFI $8.82
- LUNG $7.65
- Resistance Level
- OPFI $10.14
- LUNG $8.12
- Average True Range (ATR)
- OPFI 0.70
- LUNG 0.49
- MACD
- OPFI 0.10
- LUNG -0.06
- Stochastic Oscillator
- OPFI 41.54
- LUNG 45.71
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.